Recent changes to the PhRMA code are not having a tremendous impact on sales reps’ ability to sell target physicians on the merits of their companies’ brands, according to the results of a survey from Durham, NC-based Cutting Edge Information.
On a scale from 1 to 10, with 10 being a tremendous hindrance to sales efforts and 1 being no effect on sales efforts, companies rated the PhRMA changes as a 5.5 on average. While the overall results indicate that the code changes have not drastically impacted sales reps’ ability to access physicians, individual companies are reporting significant impact from the revisions, according to Cutting Edge’s survey.
From the April 01, 2009 Issue of MM+M - Medical Marketing and Media
